From Vir Biotech Vies for Global Approach to Tackling Infectious Disease:

Scangos Headshot—

George Scangos, CEO of Vir Biotechnology. Photo by Vir Biotechnology.

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
Xcelerating Life Sciences San Francisco: Special Report
The AI, Big Data, and R&D Boom

Sponsored · Webinar
Oct. 28 – Accelerating COVID-19 Drug Discovery: Qualified Assays for Proinflammatory Cytokines
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
Eurofins DiscoverX

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

Xconomy on Demand

We offer a number of ways to subscribe for free!